Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06047405 · ClinicalTrials.gov registry record · NA
NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP
A NA study of Hypercapnic Respiratory Failure, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06047405: Recruiting NA study of Hypercapnic Respiratory Failure, sponsored by Northwell Health.
NCT06047405 is a NA study of Hypercapnic Respiratory Failure that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06047405, a NA study of Hypercapnic Respiratory Failure, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare two different modes of noninvasive ventilation in hypercapnic respiratory failure. The investigators will compare AVAPS and BIPAP S/T and hypothesize that AVAPS will result in a decreased length of stay in the ICU or on telemetry. Currently, noninvasive ventilation is the standard of care for hypercapnic respiratory failure. However, the most effective mode for patients with hypercapnic respiratory failure is unclear.
Conditions Studied
Interventions
- DEVICE Average Volume-Assured Pressure Support (AVAPS)
- DEVICE Bilevel Positive Airway Pressure Spontaneous Timed (BIPAP S/T)
Study Locations (1)
New York
- Lenox Hill Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-10-07 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT06047405 shows while recruiting
NCT06047405 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Hypercapnic Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Average Volume-Assured Pressure Support (AVAPS) is the first listed.
NCT06047405 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06047405 about?
NCT06047405 is a clinical study titled "NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP". The goal of this study is to compare two different modes of noninvasive ventilation in hypercapnic respiratory failure. The investigators will compare AVAPS and BIPAP S/T and hypothesize that AVAPS will result in a decreased length of stay in the ICU or on telemetry. Currently, noninvasive ventilati...
What is the current status of trial NCT06047405?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-10-07. Estimated completion is 2026-09-01.
What conditions does trial NCT06047405 study?
This clinical trial studies the following conditions: Hypercapnic Respiratory Failure.
What interventions are being tested in trial NCT06047405?
The interventions under investigation include: Average Volume-Assured Pressure Support (AVAPS) (DEVICE), Bilevel Positive Airway Pressure Spontaneous Timed (BIPAP S/T) (DEVICE).
Who is sponsoring clinical trial NCT06047405?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06047405 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06047405's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI